Skip to main content
All lobbying filings

THE WASHINGTON TAX & PUBLIC POLICY GROUP

THE WASHINGTON TAX & PUBLIC POLICY GROUP filed a Q1 report for ALLIANCE FOR BIOPHARMACEUTICAL COMPETITIVENESS AND INNOVATION on April 8, 2025, reporting $450,000 in lobbying income.

Lobbying for ALLIANCE FOR BIOPHARMACEUTICAL COMPETITIVENESS AND INNOVATION · Biopharmaceutical industry

All filings by THE WASHINGTON TAX & PUBLIC POLICY GROUP · Everything ALLIANCE FOR BIOPHARMACEUTICAL COMPETITIVENESS AND INNOVATION has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 8, 2025
Income
$450,000
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 2
  • GREGORY NICKERSON
    Previously held: Tax Counsel, Ways and Means Committee; Staff Director, Ways and Means Select Revenue Measures Subcommittee
  • JAMES MAX PEDROTTI New on this filing
    Previously held: Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Deputy Chief of Staff to Rep. Carol Miller

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Taxation/Internal Revenue Code

Issues related to corporate and international taxation. Issues related to OECD Pillar 1 and Pillar 2 negotiations and agreements on the taxation of global income and the potential impacts on the tax base of the U.S. and its Territories. Issues related to IRC sections 11, 164(a), 951A, 250, 163(j), 168, 174 and 41. (H.R.1990, H.R. 574, H.R. 1062, S. 187). Issues related to interest deductibility. (H.R. 1347, S. 559)

 Bills named in this filing 6

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem